Dishman Pharmaceuticals and Chemicals Limited offers Calcitriol Medicine for Osteoporosis Treatment. Dishman Pharmaceuticals and Chemicals Limited has been awarded ISO 9001 certifications. Calcitriol Medicine for Osteoporosis Treatment is obtained from a product released during the production of vitamin D3. Calcitriol Medicine for Osteoporosis Treatment is especially used to prevent decalcification of bones. The substance is also active against other bone growth disorders such as rickets and specific liver and parathyroid glands abnormalities. Another area of treatment is psoriasis. It is practically insoluble in water; freely soluble in alcohol; soluble in ether and fatty oils.